# Alto Neuroscience (ANRO): value investors who own it

0 value investors held Alto Neuroscience in their Q3 2026 13F. See who bought, sold and how ownership has changed by quarter.

## 13F holders

| Manager | Portfolio | Value | Change | Quarters held |
| --- | --- | --- | --- | --- |
| Polen Capital Management | 0.0% | $0k | Sold out | 1 |

## Directors buying and selling (Form 4, last 12 months)

| Date | Who | Role | Bought or sold | Shares | Value |
| --- | --- | --- | --- | --- | --- |
| 2026-09-30 | Smith Nicholas Conrad | PRESIDENT AND CFO | Sold | 23170 | $597k |
| 2026-09-30 | Smith Nicholas Conrad | PRESIDENT AND CFO | Sold | 886 | $24k |
| 2026-09-29 | Smith Nicholas Conrad | PRESIDENT AND CFO | Sold | 110830 | $2.9m |

Source: SEC filings, via moatshark (https://www.moatshark.com/s/anro). Values traded and returns are estimates. Not investment advice. Built 2026-10-21.